MedTrace Logo

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

NCT06633224 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2025-09-16

No results posted yet for this study

Summary

Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.

Conditions

Interventions

PROCEDURE

Blood Specimen Collection

Blood samples will be obtained throughout the course of the study

OTHER

Stool Specimen Collection

Stool samples will be obtained throughout the course of the study

OTHER

Quality of Life (QOL) Questionnaires

Surveys will be given throughout the course of the study.

Sponsors & Collaborators

Principal Investigators

  • Sue Yom, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-27
Primary Completion
2026-09-01
Completion
2027-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06633224 on ClinicalTrials.gov